Duration of Severe Neutropenia After the Same-Day, Varying Dosing Time Schedules of Eflapegrastim Administration in Patients With Breast-Cancer Receiving Docetaxel and Cyclophosphamide
Conditions: Neutropenia; Breast Cancer Interventions: Drug: Eflapegrastim; Drug: Docetaxel; Drug: Cyclophosphamide Sponsor: Spectrum Pharmaceuticals, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials